Hasenburg, A <br/><br/>
Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up.  [electronic resource] 

 -  Gynecologic oncology  Dec 2001 
 - 549-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.2001.6442  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyclovir--pharmacokinetics<br/>Adenoviridae--enzymology<br/>Adult<br/>Aged<br/>Antineoplastic Agents--pharmacokinetics<br/>Antiviral Agents--pharmacokinetics<br/>Combined Modality Therapy<br/>Enzyme Inhibitors--pharmacokinetics<br/>Female<br/>Genetic Therapy--methods<br/>Humans<br/>Middle Aged<br/>Ovarian Neoplasms--drug therapy<br/>Second-Look Surgery<br/>Thymidine Kinase--genetics<br/>Topotecan--pharmacokinetics